(Q38382234)

2 September 2017

Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial (English)

1 reference

2 September 2017

0 references

1 reference

M Engman

1

1 reference

2 September 2017

S Granberg

2

1 reference

2 September 2017

A R W Williams

3

1 reference

2 September 2017

C X Meng

4

1 reference

2 September 2017

P G L Lalitkumar

5

1 reference

2 September 2017

K Gemzell-Danielsson

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

23 April 2009

1 reference

2 September 2017

1 reference

2 September 2017

24

1 reference

2 September 2017

8

1 reference

2 September 2017

1870-1879

1 reference

Mifepristone: a novel estrogen-free daily contraceptive pill

2 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Clinical features of myomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Etiology and pathogenesis of uterine leiomyomas: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

The spectrum of endometrial pathology induced by progesterone receptor modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Systematic review of mifepristone for the treatment of uterine leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Clinical symptomatology of uterine leiomyomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Uterine myomas: an overview of development, clinical features, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

Self-reported heavy bleeding associated with uterine leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP100

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEP100

1 reference

2 September 2017

1 reference